Best CRT - D Hospitals in India

Choosing Fortis Hospital, Shalimar Bagh for CRT - D gives patients access to experienced cardiac specialists, advanced electrophysiology technology, and comprehensive cardiovascular care. Established in 2010, the NABH hospital in Delhi, India has 262 beds and provides specialised cardiac services.

CRT-D may be considered for patients with certain types of heart failure who have reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The device delivers coordinated electrical stimulation to improve ventricular synchrony while providing defibrillation therapy when needed. Before implantation, doctors perform cardiac investigations to assess heart rhythm, ventricular function, and the risk of serious arrhythmias. Follow-up visits help monitor the device and the patient's response.

Wockhardt Hospital - A new Age Hospital provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 2014, the NABH, NABL, JCI hospital is located in Mumbai, India, and operates 350 beds, equipped with modern healthcare infrastructure.

CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.

At Seven Hills Hospital, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 1986, this NABH, NABL, JCI hospital in Mumbai, India has 1500 beds and provides comprehensive cardiovascular care.

CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.

Sri Ramachandra Medical Centre offers advanced CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) using modern cardiac electrophysiology techniques and internationally accepted treatment protocols. Established in 1985, the JCI, NABH hospital is located in Chennai, India and has 1800 beds, providing comprehensive care for local and international patients.

CRT-D is a device-based treatment for selected patients with heart failure and abnormal electrical conduction that causes the ventricles to beat out of sync. The device helps coordinate the heart's ventricular contractions and can also deliver an electrical shock when a life-threatening abnormal heart rhythm occurs. Before implantation, doctors evaluate heart rhythm, ventricular function, and overall cardiac health. Regular follow-up is required to monitor device function and adjust treatment when necessary.

Max Smart Super Speciality Hospital provides specialised CRT - D with a focus on patient safety, precise device implantation, and long-term cardiac care. Established in 2012, the JCI, NABH hospital is located in Delhi, India, and operates 250 beds, equipped with modern healthcare infrastructure.

CRT-D (Cardiac Resynchronisation Therapy with Defibrillator) is designed to provide both ventricular resynchronisation and protection against certain life-threatening abnormal heart rhythms. It is used in carefully selected patients with heart failure and specific electrical conduction abnormalities. The device uses leads to deliver electrical impulses that coordinate ventricular contractions and can deliver a shock when required to terminate certain dangerous rhythms. Comprehensive cardiac evaluation before implantation and ongoing device follow-up are important parts of treatment.

Choosing Apollo Spectra Hospital for CRT - D gives patients access to experienced cardiac specialists, advanced electrophysiology technology, and comprehensive cardiovascular care. Established in 2012, the NABH, NABL hospital in Pune, India has 30 beds and provides specialised cardiac services.

CRT-D may be considered for patients with certain types of heart failure who have reduced pumping function and an electrical conduction abnormality that causes the ventricles to contract asynchronously. The device delivers coordinated electrical stimulation to improve ventricular synchrony while providing defibrillation therapy when needed. Before implantation, doctors perform cardiac investigations to assess heart rhythm, ventricular function, and the risk of serious arrhythmias. Follow-up visits help monitor the device and the patient's response.

Max Super Specialty Hospital, Shalimar Bagh is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 2011, the NABH, NABL hospital is situated in Delhi, India and has 402 beds.

CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.

At Amrita Hospital, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 2022, this NABH hospital in Faridabad, India has 2600 beds and provides comprehensive cardiovascular care.

CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.

Marengo Asia Hospitals, Faridabad is a trusted healthcare provider for CRT - D, offering advanced cardiac rhythm management supported by experienced specialists and modern medical infrastructure. Established in 2007, the NABH, NABL hospital is situated in Faridabad, India and has 325 beds.

CRT-D is a specialised cardiac device that combines resynchronisation therapy with defibrillator protection. It may help selected patients whose heart failure is associated with abnormal electrical conduction and an increased risk of serious ventricular arrhythmias. During implantation, leads are positioned in the heart and connected to a pulse generator placed under the skin. Doctors assess cardiac function and electrical activity before the procedure, and then perform regular monitoring to ensure proper device performance.

At Marengo Asia Hospitals, Gurugram, CRT - D is performed using advanced cardiac device implantation techniques and personalised treatment plans based on the patient's condition. Established in 2022, this NABH, NABL hospital in Gurgaon, India has 250 beds and provides comprehensive cardiovascular care.

CRT-D may be recommended for selected patients with heart failure, reduced heart function, and electrical conduction abnormalities that lead to poorly coordinated ventricular contractions. The device combines cardiac resynchronisation therapy with an implantable cardioverter-defibrillator. It delivers electrical impulses to help synchronise ventricular contractions and can provide therapy for certain dangerous heart rhythms. Before implantation, patients typically undergo ECG, echocardiography, and other cardiac assessments to determine whether CRT-D is appropriate.